PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Histology

Clinical trial NCT01387711 · COMPLETED

Trial details

NCT number: NCT01387711
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2011-08-01
Primary completion: 2012-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.